US court gives preliminary approval to Indegene Inc TCPA class action settlement
INDGN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.2 pts more than Nifty Smallcap 250 and 1.8 pts more than its Healthcare Research Analytics & Technology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
A US District Court in New Jersey has preliminarily approved a class action settlement involving Indegene's wholly-owned US subsidiary, Indegene Inc., under the Telephone Consumer Protection Act. The settlement has a maximum fund of about USD 4.72 million with USD 250 per approved claim on a claims-made basis. No pre-funding of the full amount is required and no payments have been made yet. Final approval hearing is set for 12 January 2027.
Positive step toward resolving the TCPA lawsuit. Actual cash outflow depends on claims received and no upfront funding of the full amount is required.